The group's principle activity is to focus on research and development of vaccines for established and emerging infectious diseases. The group operates from United States.
Executive Information
Name
Title
Email
Carolyn Weeks-Levy
Chief Scientific Officer
N/A
David Vandertie
CFO
N/A
Beth-Ann Coller
VP - Research, Development
N/A
Richard Sherman
Dir., Sr. VP - Business Development, General Counsel
